Xcenda's FormularyDecisions Launches Resource Hub for Biosimilars
Shots:
- FormularyDecisions’ new feature will provide registered users with centralized access to pertinent product and drug pipeline information- regulatory guidance and state-specific substitution laws
- The biosimilar hub will provide users an interactive chart of the US biosimilar market landscape- curated biosimilar resources and dynamic repository of state substitution laws for biosimilar products
- With the hub- the company is providing the payers with information at all stages of the product lifecycle in an easily accessible format- ultimately helping to enhance the formulary decision-making process
Ref: Businesswire | Image: Twitter
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com